PCM
ABBV icon

Payne Capital Management’s AbbVie ABBV Stock Holding History

Payne Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$345K Buy
1,372
+306
+29% +$65.8K 0.09% 65
2026
Q1 		$232K Sell
1,066
-85
-7% -$18.9K 0.07% 72
2025
Q4 		$263K Buy
1,151
+76
+7% +$17.3K 0.08% 65
2025
Q3 		$249K Sell
1,075
-11
-1% -$2.24K 0.08% 64
2025
Q2 		$201K Sell
1,086
-99
-8% -$18.4K 0.08% 77
2025
Q1 		$248K Buy
+1,185
New +$230K 0.11% 57

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Payne Capital Management's ABBV Position: Q2 2026 in Review

Payne Capital Management increased its AbbVie (ABBV) stake by 29% in Q2 2026, buying an estimated $65.8K and bringing the position to 1,372 shares worth $345K. The position accounts for 0.09% of the portfolio, ranked #65.

Payne Capital Management first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Payne Capital Management held 1,372 shares of AbbVie worth $345K as of Q2 2026.
  • Payne Capital Management bought 306 AbbVie shares in Q2 2026, an estimated $65.8K.
  • AbbVie made up 0.09% of Payne Capital Management's portfolio in Q2 2026, its #65 holding.
  • Payne Capital Management first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • 4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Payne Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.